Bogale Aredo1, Tao Li2, Xiao Chen1, Kaiyan Zhang1, Cynthia Xin-Zhao Wang1, Darlene Gou1, Biren Zhao1, Yuguang He1, Rafael L Ufret-Vincenty1. 1. Department of Ophthalmology UT Southwestern Medical Center, Dallas, Texas, United States. 2. Department of Ophthalmology UT Southwestern Medical Center, Dallas, Texas, United States 2Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Abstract
PURPOSE: Variants of complement factor H (Cfh) affecting short consensus repeats (SCRs) 6 to 8 increase the risk of age-related macular degeneration. Our aim was to explore the effect of expressing a Cfh variant on the in vivo susceptibility of the retina and RPE to oxidative stress and inflammation, using chimeric Cfh transgenic mice (chCfhTg). METHODS: The chCfhTg and age-matched C57BL/6J (B6) mice were subjected to oxidative stress by either normal aging, or by exposure to a combination of oral hydroquinone (0.8% HQ) and increased light. Eyes were collected for immunohistochemistry of RPE-choroid flat mounts and of retinal sections, ELISA, electron microscopy, and RPE/microglia gene expression analysis. RESULTS: Aging mice to 2 years led to an increased accumulation of basal laminar deposits, subretinal microglia/macrophages (MG/MΦ) staining for CD16 and for malondialdehyde (MDA), and MDA-modified proteins in the retina in chCfhTg compared to B6 mice. The chCfhTg mice maintained on HQ diet and increased light showed greater deposition of basal laminar deposits, more accumulation of fundus spots suggestive of MG/MΦ, and increased deposition of C3d in the sub-RPE space, compared to controls. In addition, chCfhTg mice demonstrated upregulation of NLRP3, IP-10, CD68, and TREM-2 in the RNA isolates from RPE/MG/MΦ. CONCLUSIONS: Expression of a Cfh transgene introducing a variant in SCRs 6 to 8 was sufficient to lead to increased retinal/RPE susceptibility to oxidative stress, a proinflammatory MG/MΦ phenotype, and a proinflammatory RPE/MG/MΦ gene expression profile in a transgenic mouse model. Our data suggest that altered interactions of Cfh with MDA-modified proteins may be relevant in explaining the effects of the Cfh variant.
PURPOSE: Variants of complement factor H (Cfh) affecting short consensus repeats (SCRs) 6 to 8 increase the risk of age-related macular degeneration. Our aim was to explore the effect of expressing a Cfh variant on the in vivo susceptibility of the retina and RPE to oxidative stress and inflammation, using chimeric Cfhtransgenic mice (chCfhTg). METHODS: The chCfhTg and age-matched C57BL/6J (B6) mice were subjected to oxidative stress by either normal aging, or by exposure to a combination of oral hydroquinone (0.8% HQ) and increased light. Eyes were collected for immunohistochemistry of RPE-choroid flat mounts and of retinal sections, ELISA, electron microscopy, and RPE/microglia gene expression analysis. RESULTS: Aging mice to 2 years led to an increased accumulation of basal laminar deposits, subretinal microglia/macrophages (MG/MΦ) staining for CD16 and for malondialdehyde (MDA), and MDA-modified proteins in the retina in chCfhTg compared to B6 mice. The chCfhTgmice maintained on HQ diet and increased light showed greater deposition of basal laminar deposits, more accumulation of fundus spots suggestive of MG/MΦ, and increased deposition of C3d in the sub-RPE space, compared to controls. In addition, chCfhTgmice demonstrated upregulation of NLRP3, IP-10, CD68, and TREM-2 in the RNA isolates from RPE/MG/MΦ. CONCLUSIONS: Expression of a Cfh transgene introducing a variant in SCRs 6 to 8 was sufficient to lead to increased retinal/RPE susceptibility to oxidative stress, a proinflammatory MG/MΦ phenotype, and a proinflammatory RPE/MG/MΦ gene expression profile in a transgenic mouse model. Our data suggest that altered interactions of Cfh with MDA-modified proteins may be relevant in explaining the effects of the Cfh variant.
Authors: Diego G Espinosa-Heidmann; Ivan J Suner; Paola Catanuto; Eleut P Hernandez; Maria E Marin-Castano; Scott W Cousins Journal: Invest Ophthalmol Vis Sci Date: 2006-02 Impact factor: 4.799
Authors: Maria E Marin-Castaño; Gary E Striker; Oscar Alcazar; Paola Catanuto; Diego G Espinosa-Heidmann; Scott W Cousins Journal: Invest Ophthalmol Vis Sci Date: 2006-09 Impact factor: 4.799
Authors: J Renwick Beattie; Anna M Pawlak; Michael E Boulton; Jianye Zhang; Vincent M Monnier; John J McGarvey; Alan W Stitt Journal: FASEB J Date: 2010-08-04 Impact factor: 5.191
Authors: Narkunarajaa Shanmugam; James L Figarola; Yan Li; Piotr M Swiderski; Samual Rahbar; Rama Natarajan Journal: Diabetes Date: 2007-11-14 Impact factor: 9.461
Authors: Carsten Faber; Jennifer Williams; Helene Bæk Juel; John Greenwood; Mogens Holst Nissen; Stephen E Moss Journal: Invest Ophthalmol Vis Sci Date: 2012-09-19 Impact factor: 4.799
Authors: Anu Kauppinen; Jussi J Paterno; Janusz Blasiak; Antero Salminen; Kai Kaarniranta Journal: Cell Mol Life Sci Date: 2016-02-06 Impact factor: 9.261
Authors: Minh Thuan Nguyen Tran; Mohd Khairul Nizam Mohd Khalid; Alice Pébay; Anthony L Cook; Helena H Liang; Raymond C B Wong; Jamie E Craig; Guei-Sheung Liu; Sandy S Hung; Alex W Hewitt Journal: Mol Vis Date: 2019-03-16 Impact factor: 2.367
Authors: Yuanfei Zhu; Bogale Aredo; Bo Chen; Cynthia X Zhao; Yu-Guang He; Rafael L Ufret-Vincenty Journal: Invest Ophthalmol Vis Sci Date: 2019-09-03 Impact factor: 4.799
Authors: Malgorzata Rozanowska; Ruth Edge; Edward J Land; Suppiah Navaratnam; Tadeusz Sarna; T George Truscott Journal: Int J Mol Sci Date: 2019-06-07 Impact factor: 5.923
Authors: Alan J Mouton; Kristine Y DeLeon-Pennell; Osvaldo J Rivera Gonzalez; Elizabeth R Flynn; Tom C Freeman; Jeffrey J Saucerman; Michael R Garrett; Yonggang Ma; Romain Harmancey; Merry L Lindsey Journal: Basic Res Cardiol Date: 2018-06-04 Impact factor: 17.165